Nimbus Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States51-200 Employees

Nimbus Therapeutics, based in Boston, Massachusetts, is a biotechnology research company focused on clinical-stage, structure-based discovery of small-molecule medicines targeting targets that are validated but challenging to modulate across multiple diseases. The company employs computational technologies together with machine-learning-based predictive modeling to advance its research. Its pipeline includes a clinical-stage HPK1 inhibitor for cancer (NCT05128487) and a broad set of preclinical programs, including WRN inhibitors for MSI-H cancers, as well as initiatives in autoimmune and metabolic diseases. Nimbus has engaged in collaborations, including a multi-year, worldwide license with Eli Lilly to develop an oral treatment for obesity and other metabolic diseases, and it has publicly presented mechanistic data on its SIK2 inhibitor program at immunology conferences in 2026. The company serves a workforce of 51-200 employees and is located at 22 Boston Wharf Road, 9th Floor, Boston, Massachusetts; its website is https://nimbustx.com.

Sign up for free to view info

Company overview Employee directory